Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Early radiotherapy related morbidity

Andrew Hartley, Selvaraj Giridharan, Gulnaz Begum

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology

|July 30, 2003

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with metastatic cancer: a phase 2 single-arm, open-label trial.

Journal of leukocyte biology·2026

Same author

Effects of Isha Yoga Practices on Health Outcomes: A Systematic Review of Controlled Studies.

Cureus·2026

Same author

Advanced Magnetic Resonance Imaging Techniques for Assessing Brain Metastases Response Following Stereotactic Radiosurgery.

World neurosurgery·2026

Same author

Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1.

Journal for immunotherapy of cancer·2025

Same author

Effects of Yoga Interventions on Health Outcomes in Women With Gynecological Cancers: A Systematic Review of Randomised Controlled Trials.

Cureus·2025

Same author

Hepatic zonation determines tumorigenic potential of mutant β-catenin.

Nature·2025